Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
UK clinical experience up to 52 weeks with linaclotide for irritable bowel syndrome with constipation.
Yiannakou Y, Agrawal A, Allen PB, Arebi N, Brown SR, Eugenicos MP, Farmer AD, McLain-Smith S, McLaughlin J, Sanders DS, Lawrance D, Emmanuel A. Yiannakou Y, et al. Among authors: eugenicos mp. Therap Adv Gastroenterol. 2018 Oct 3;11:1756284818798791. doi: 10.1177/1756284818798791. eCollection 2018. Therap Adv Gastroenterol. 2018. PMID: 30302125 Free PMC article.
Treatment of irritable bowel syndrome with diarrhoea using titrated ondansetron (TRITON): study protocol for a randomised controlled trial.
Gunn D, Fried R, Lalani R, Farrin A, Holloway I, Morris T, Olivier C, Kearns R, Corsetti M, Scott M, Farmer A, Emmanuel A, Whorwell P, Yiannakou Y, Sanders D, Mclaughlin J, Kapur K, Eugenicos M, Akbar A, Trudgill N, Houghton L, Dinning PG, Ford AC, Aziz Q, Spiller R. Gunn D, et al. Trials. 2019 Aug 20;20(1):517. doi: 10.1186/s13063-019-3562-6. Trials. 2019. PMID: 31429811 Free PMC article.
Randomised, placebo-controlled trial and meta-analysis show benefit of ondansetron for irritable bowel syndrome with diarrhoea: The TRITON trial.
Gunn D, Topan R, Barnard L, Fried R, Holloway I, Brindle R, Corsetti M, Scott M, Farmer A, Kapur K, Sanders D, Eugenicos M, Trudgill N, Whorwell P, Mclaughlin J, Akbar A, Houghton L, Dinning PG, Aziz Q, Ford AC, Farrin AJ, Spiller R. Gunn D, et al. Aliment Pharmacol Ther. 2023 Jun;57(11):1258-1271. doi: 10.1111/apt.17426. Epub 2023 Mar 3. Aliment Pharmacol Ther. 2023. PMID: 36866724 Free article.
The national prevalence of disorders of gut brain interaction in the United Kingdom in comparison to their worldwide prevalence: Results from the Rome foundation global epidemiology study.
Jaafari H, Houghton LA, West RM, Agrawal A, Aziz I, Black CJ, Corsetti M, Shuweihdi F, Eugenicos M, Paine PA, Ford AC, Whorwell PJ, Bangdiwala SI, Palsson OS, Sperber AD, Vasant DH. Jaafari H, et al. Neurogastroenterol Motil. 2023 Jun;35(6):e14574. doi: 10.1111/nmo.14574. Epub 2023 Apr 5. Neurogastroenterol Motil. 2023. PMID: 37018424 Free article.
Scan-Negative Cauda Equina Syndrome: A Prospective Cohort Study.
Hoeritzauer I, Carson A, Statham P, Panicker JN, Granitsiotis V, Eugenicos M, Summers D, Demetriades AK, Stone J. Hoeritzauer I, et al. Neurology. 2021 Jan 19;96(3):e433-e447. doi: 10.1212/WNL.0000000000011154. Epub 2020 Nov 11. Neurology. 2021. PMID: 33177221
11 results